DOP07: IMP761, a novel anti-LAG-3 agonist antibody for the treatment of auto-immune diseasesM. Angin, C. Brignone, F. TriebelImmutep, Orsay, France
this I want to hear about
- Forums
- ASX - By Stock
- IMM
- Ann: TACTI-mel data presented at World Immunotherapy Congress
Ann: TACTI-mel data presented at World Immunotherapy Congress, page-30
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.3¢ | $854.7K | 2.741M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 527 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 0.395 |
3 | 76000 | 0.390 |
4 | 68064 | 0.385 |
10 | 225656 | 0.380 |
1 | 8500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 37481 | 2 |
0.410 | 240538 | 10 |
0.415 | 229395 | 10 |
0.420 | 502644 | 9 |
0.425 | 50700 | 3 |
Last trade - 15.59pm 27/11/2024 (20 minute delay) ? |
IMM (ASX) Chart |